Emerging methods for prostate cancer imaging: evaluating cancer structure and metabolic alterations more clearly.
MRI
PET
biomarker
imaging
metabolism
prostate cancer
Journal
Molecular oncology
ISSN: 1878-0261
Titre abrégé: Mol Oncol
Pays: United States
ID NLM: 101308230
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
revised:
09
07
2021
received:
22
12
2020
accepted:
29
07
2021
pubmed:
31
7
2021
medline:
8
4
2022
entrez:
30
7
2021
Statut:
ppublish
Résumé
Imaging plays a fundamental role in all aspects of the cancer management pathway. However, conventional imaging techniques are largely reliant on morphological and size descriptors that have well-known limitations, particularly when considering targeted-therapy response monitoring. Thus, new imaging methods have been developed to characterise cancer and are now routinely implemented, such as diffusion-weighted imaging, dynamic contrast enhancement, positron emission technology (PET) and magnetic resonance spectroscopy. However, despite the improvement these techniques have enabled, limitations still remain. Novel imaging methods are now emerging, intent on further interrogating cancers. These techniques are at different stages of maturity along the biomarker pathway and aim to further evaluate the cancer microstructure (vascular, extracellular and restricted diffusion for cytometry in tumours) magnetic resonance imaging (MRI), luminal water fraction imaging] as well as the metabolic alterations associated with cancers (novel PET tracers, hyperpolarised MRI). Finally, the use of machine learning has shown powerful potential applications. By using prostate cancer as an exemplar, this Review aims to showcase these potentially potent imaging techniques and what stage we are at in their application to conventional clinical practice.
Identifiants
pubmed: 34328279
doi: 10.1002/1878-0261.13071
pmc: PMC8486595
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2565-2579Subventions
Organisme : Cancer Research UK
Pays : United Kingdom
Informations de copyright
© 2021 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
Références
IEEE Trans Med Imaging. 2019 Nov;38(11):2496-2506
pubmed: 30835218
Nucl Med Mol Imaging. 2011 Mar;45(1):1-14
pubmed: 24899972
J Magn Reson Imaging. 2015 Oct;42(4):1072-7
pubmed: 25704897
Eur Urol. 2017 Dec;72(6):1028-1029
pubmed: 28765011
Radiology. 2019 May;291(2):273-284
pubmed: 30835184
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Cancers (Basel). 2020 May 28;12(6):
pubmed: 32481661
Eur Urol. 2019 Apr;75(4):570-578
pubmed: 30477981
Curr Probl Diagn Radiol. 2015 Sep-Oct;44(5):407-24
pubmed: 25890454
Clin Cancer Res. 2007 Jun 15;13(12):3449-59
pubmed: 17575207
Lancet Gastroenterol Hepatol. 2018 Jun;3(6):433-443
pubmed: 29739674
BMC Cancer. 2020 Feb 19;20(1):134
pubmed: 32075610
AJR Am J Roentgenol. 2007 Jun;188(6):1622-35
pubmed: 17515386
AJR Am J Roentgenol. 2009 Oct;193(4):W295-300
pubmed: 19770298
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12590-5
pubmed: 14583590
Radiology. 2018 May;287(2):525-533
pubmed: 29361244
Neoplasia. 2009 Feb;11(2):102-25
pubmed: 19186405
Cancer Res. 2017 Jun 15;77(12):3207-3216
pubmed: 28428273
J Magn Reson Imaging. 2011 Mar;33(3):692-7
pubmed: 21563254
Nat Rev Clin Oncol. 2012 Feb 14;9(3):167-77
pubmed: 22330689
J Urol. 2019 Feb;201(2):322-331
pubmed: 30179618
Med Biol Eng Comput. 2020 Oct;58(10):2413-2425
pubmed: 32749555
J Magn Reson. 2019 Sep;306:124-127
pubmed: 31307893
Eur J Nucl Med Mol Imaging. 2015 Apr;42(4):579-96
pubmed: 25673052
Lancet. 2017 Feb 25;389(10071):815-822
pubmed: 28110982
Nat Rev Clin Oncol. 2017 Mar;14(3):169-186
pubmed: 27725679
AJR Am J Roentgenol. 2015 Mar;204(3):550-7
pubmed: 25714284
J Urol. 2016 May;195(5):1436-1443
pubmed: 26682756
Cancer Res. 2016 Feb 15;76(4):787-95
pubmed: 26659574
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):241-51
pubmed: 25193652
Cancer Res. 2014 Apr 1;74(7):1902-12
pubmed: 24491802
Eur Radiol. 2009 Nov;19(11):2728-38
pubmed: 19547986
Chem Soc Rev. 2014 Mar 7;43(5):1627-59
pubmed: 24363044
Radiology. 1999 Nov;213(2):530-6
pubmed: 10551237
AJR Am J Roentgenol. 2010 Aug;195(2):281-9
pubmed: 20651182
Sci Transl Med. 2013 Jul 31;5(196):196cm6
pubmed: 23903752
Lancet Oncol. 2019 Jan;20(1):100-109
pubmed: 30470502
Radiology. 2004 May;231(2):305-32
pubmed: 15044750
Radiology. 2010 Apr;255(1):89-99
pubmed: 20308447
J Clin Oncol. 2009 Sep 10;27(26):4321-6
pubmed: 19652073
J Magn Reson Imaging. 2019 Sep;50(3):910-917
pubmed: 30566264
J Nucl Med. 2003 Mar;44(3):331-5
pubmed: 12620996
Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18131-6
pubmed: 19826085
Oncotarget. 2018 Sep 18;9(73):33804-33817
pubmed: 30333911
J Clin Oncol. 2014 Jan 1;32(1):34-43
pubmed: 24276776
Radiology. 1998 Apr;207(1):123-30
pubmed: 9530307
Contemp Clin Trials. 2015 May;42:26-40
pubmed: 25749312
Radiographics. 2009 Oct;29(6):1653-64
pubmed: 19959513
NMR Biomed. 1999 Nov;12(7):413-39
pubmed: 10654290
Eur Radiol. 2007 Jan;17(1):23-32
pubmed: 16683115
J Immunother Cancer. 2018 Jan 15;6(1):2
pubmed: 29332608
Insights Imaging. 2019 Mar 4;10(1):28
pubmed: 30830470
Cancer Treat Rev. 2008 Apr;34(2):103-21
pubmed: 18055120
World J Nucl Med. 2017 Jan-Mar;16(1):21-25
pubmed: 28217015
AJR Am J Roentgenol. 2018 Sep;211(3):470-484
pubmed: 29995496
Sci Transl Med. 2013 Aug 14;5(198):198ra108
pubmed: 23946197
Elife. 2017 Jul 21;6:
pubmed: 28731408
Radiol Infect Dis. 2018 Mar;5(1):7-13
pubmed: 31692939
Urology. 2007 Dec;70(6 Suppl):27-35
pubmed: 18194708
Eur Radiol. 2017 Oct;27(10):4082-4090
pubmed: 28374077
Radiographics. 2016 Jan-Feb;36(1):279-92
pubmed: 26761541
Eur J Cancer. 2012 Mar;48(4):409-15
pubmed: 22226478
Magn Reson Med. 2012 Sep;68(3):954-9
pubmed: 22162114
World J Urol. 2007 Mar;25(1):3-9
pubmed: 17364211
Radiographics. 2006 Oct;26 Suppl 1:S205-23
pubmed: 17050517
J Magn Reson Imaging. 2008 Jan;27(1):132-9
pubmed: 18050334
J Nucl Med. 2016 Feb;57 Suppl 1:17S-26S
pubmed: 26834096
Neuroimaging Clin N Am. 2010 Aug;20(3):293-310
pubmed: 20708548
Magn Reson Med. 2008 Sep;60(3):510-6
pubmed: 18727052
Magn Reson Imaging Clin N Am. 2009 May;17(2):277-89
pubmed: 19406359
Eur Urol. 2013 Dec;64(6):876-92
pubmed: 23787356
Magn Reson Med. 1991 Feb;17(2):357-67
pubmed: 2062210
Cancer Res. 2013 Jan 15;73(2):529-38
pubmed: 23204238
Eur J Nucl Med Mol Imaging. 2004 Mar;31(3):317-24
pubmed: 14628097
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10158-63
pubmed: 12930897
Eur Radiol. 2008 Jul;18(7):1307-18
pubmed: 18389253
Neoplasia. 2019 Jan;21(1):1-16
pubmed: 30472500
J Comput Assist Tomogr. 2009 Nov-Dec;33(6):863-6
pubmed: 19940651
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19801-6
pubmed: 19903889
Radiology. 2017 Aug;284(2):451-459
pubmed: 28394754
N Engl J Med. 2018 May 10;378(19):1767-1777
pubmed: 29552975
Radiology. 2019 Dec;293(3):607-617
pubmed: 31592731
Radiology. 2019 May;291(2):391-397
pubmed: 30938627
Pharmaceuticals (Basel). 2017 Jul 31;10(3):
pubmed: 28758969
Front Oncol. 2018 Feb 16;8:26
pubmed: 29503808
NMR Biomed. 2019 Feb;32(2):e4048
pubmed: 30575145
Br J Radiol. 2009 Feb;82(974):148-56
pubmed: 19168692
NMR Biomed. 2019 Mar;32(3):e4052
pubmed: 30664305
NMR Biomed. 2013 Dec;26(12):1696-704
pubmed: 23946252
Eur Radiol. 2017 Oct;27(10):4200-4208
pubmed: 28386721
Nat Rev Urol. 2020 Jan;17(1):41-61
pubmed: 31316185
Eur Radiol. 2019 Oct;29(10):5559-5566
pubmed: 30888488
BMC Cancer. 2016 Oct 21;16(1):816
pubmed: 27769214
Ther Adv Med Oncol. 2019 Sep 20;11:1758835919876828
pubmed: 31565073
Lancet. 2014 Jan 11;383(9912):101-4
pubmed: 24411643
AJR Am J Roentgenol. 2019 Aug;213(2):384-396
pubmed: 31039022
J Nucl Med. 2015 May;56(5):668-74
pubmed: 25791990
Invest Radiol. 2015 Apr;50(4):218-27
pubmed: 25426656
Med Phys. 2020 Jun;47(5):e185-e202
pubmed: 32418336
J Urol. 2008 Jan;179(1):34-45
pubmed: 17997425
Med Phys. 2018 Oct;45(10):e834-e840
pubmed: 30144098
Cell Metab. 2020 Jan 7;31(1):105-114.e3
pubmed: 31564440
NMR Biomed. 2019 May;32(5):e4073
pubmed: 30779863
Oncotarget. 2017 May 10;8(35):59492-59499
pubmed: 28938652
Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1285-9
pubmed: 16802155
J Urol. 1996 Mar;155(3):994-8
pubmed: 8583625
Radiology. 2011 Oct;261(1):46-66
pubmed: 21931141
Radiology. 1988 Aug;168(2):497-505
pubmed: 3393671
Br J Radiol. 2011 May;84(1001):435-40
pubmed: 21081583
J Nucl Med. 2018 Jul;59(7):1007-1013
pubmed: 29674422
AJR Am J Roentgenol. 2018 Mar;210(3):549-556
pubmed: 29220213
Nature. 2008 Jun 12;453(7197):940-3
pubmed: 18509335
J Magn Reson Imaging. 1999 Sep;10(3):223-32
pubmed: 10508281
AJNR Am J Neuroradiol. 2009 Mar;30(3):544-51
pubmed: 19095788
J Magn Reson. 2016 Mar;264:3-12
pubmed: 26920825
BJU Int. 2006 May;97(5):923-31
pubmed: 16643472
Clin Imaging. 2020 Mar;60(1):123-130
pubmed: 31874336
Radiographics. 2013 Sep-Oct;33(5):1323-41
pubmed: 24025927